# POST_PHASE_STRATEGY_REVIEW
_Date: 2026-05-05 · Scope: Post-T24 Phase 0 foundation strategy review_

## Executive Summary

Recommendation: CONDITIONAL_GO.

The Phase 0 foundation is strategically aligned with the Entropy Protocol
direction: it builds deterministic, leakage-aware, auditable research
infrastructure before any trading-edge claim. T01-T24 now cover the intended
foundation surface from registry and hashing through walk-forward, attribution,
governance, statistics stubs, and evidence artifacts.

The condition is important: this is not yet approval to start Phase 1 trading or
performance work. The foundation should first go through a short closure and
hardening phase that resolves documentation drift, locks the next evidence
semantics, and separates implementation evidence from research validation.

## Strategic Fit

Verdict: ALIGNED.

What was built:

- deterministic project/runtime foundation with 135 passing tests;
- append-only trial registry and reproducibility hash boundaries;
- local fixture data path and deterministic Parquet storage;
- SimBroker cost/fill/calibration surfaces;
- walk-forward split, leakage checklist, and OOS block;
- four-stream attribution with stream (d) excluded from Net Sharpe;
- P1/P3 governance state machine;
- provisional statistical helpers for CI, Harvey-Liu, and N_eff;
- Phase 0 implementation-evidence reports with `NOT_APPROVED` default.

This fits the project vector because the system now makes it harder to produce
untracked or leakage-contaminated claims. The useful foundation should be
preserved. The provisional formula and evidence surfaces should be hardened
before any later phase relies on them.

## Protocol Fit

Verdict: SAFE_FOUNDATION.

The implementation respects the central protocol posture: no live capital, no
OOS performance claim, no automatic phase-gate approval. D-017 through D-020
kept formula/evidence work bounded and task-specific.

Remaining caution areas:

- Harvey-Liu, Sharpe CI, and N_eff are still foundation stubs.
- Purge/embargo is still a temporary N-consecutive-bar assumption.
- P4 is still out of implementation scope.
- F-30 and F-31 remain future real-evidence gates.
- Phase gate approval remains `NOT_APPROVED` pending human review.

No stub or synthetic test should be cited as research validation.

## Architecture Fit

Verdict: ALIGNED WITH DOCUMENTATION REMEDIATION NEEDED.

The implementation stays inside the declared Python/T1/deterministic runtime
shape. No runtime LLM path, network egress, non-Python toolchain, FFI, or new
service was introduced.

The main architecture issue is documentation freshness: `products/entropy-core/docs/audit/REVIEW_REPORT.md`
still describes the Phase 8 boundary review and baseline 125, while the actual
current foundation state is T24 complete with baseline 135. `CODEX_PROMPT.md`
and `PHASE0_FOUNDATION_REVIEW.md` are current; `REVIEW_REPORT.md` should be
updated before it is treated as the latest consolidated review.

## Evidence/Test Fit

Verdict: SUFFICIENT_FOR_FOUNDATION.

The current baseline is suitable for a foundation checkpoint:

- 135 passing tests with PostgreSQL 16 Docker container;
- ruff check and format check pass;
- pyright reports 0 errors;
- evidence index points to heavy-task, statistical-stub, and phase-gate artifact
  tests.

This is implementation evidence only. Missing before claims:

- independent formula audit for Harvey-Liu and Sharpe CI;
- real RDL telemetry for F-30;
- real K-report epoch coverage for F-31;
- production purge/embargo derivation;
- human approval event/review record for Phase 0 gate.

## Fix Queue

| ID | Severity | Owner | Files | Why It Matters | Recommended Action |
|----|----------|-------|-------|----------------|--------------------|
| PSR-001 | P1 | strategist | `products/entropy-core/docs/audit/REVIEW_REPORT.md`, `products/entropy-core/docs/audit/AUDIT_INDEX.md` | Canonical consolidated review is stale after T23/T24. Future agents may rely on Phase 8 stop-ship state instead of current T24 foundation state. | Write a Phase 0 consolidated review or update `REVIEW_REPORT.md` to point to `PHASE0_FOUNDATION_REVIEW.md` and baseline 135. |
| PSR-002 | P1 | human | `products/entropy-core/docs/audit/PHASE0_FOUNDATION_REVIEW.md`, `products/entropy-core/docs/CODEX_PROMPT.md` | Phase 0 implementation is complete but not approved. Next implementation should not start until the human chooses closure/hardening/Phase 1 direction. | Record a human Phase 0 foundation decision: accept foundation, request fixes, or reject/reshape. |
| PSR-003 | P2 | codex | `products/entropy-core/docs/tasks.md`, `products/entropy-core/docs/EVIDENCE_INDEX.md` | Next-stage tasks are not yet represented as executable task graph entries. | After human decision, add a Phase 0 hardening or Phase 1 planning task block with acceptance tests/evidence. |
| PSR-004 | P2 | strategist | `products/entropy-core/docs/ARCHITECTURE.md`, `products/entropy-core/docs/spec.md` | Architecture/spec still describe some future surfaces at a high level; post-T24 reality should be summarized before the next phase. | Add a short "Phase 0 Foundation Status" section or update existing component notes. |
| PSR-005 | P2 | human/strategist | `products/entropy-core/docs/adr/`, `products/entropy-core/docs/core/*` | Formula and evidence debt remains intentionally open. | Decide whether to open ADR/review packets for Harvey-Liu, Sharpe CI, purge/embargo, N_eff/K3, F-30, F-31 before Phase 1. |

## Next Phase Recommendation

Recommended next phase: Phase 0 Closure and Hardening, not Phase 1 implementation
yet.

Objective:

Convert the T01-T24 implementation foundation into an explicitly reviewed,
human-accepted baseline, with documented hardening priorities and a clean task
graph for the next development stage.

Recommended boundaries:

- No live capital.
- No OOS performance claim.
- No external data provider activation by default.
- No RDL/K-report closure unless real artifacts exist.
- No formula claims beyond reviewed and approved methods.

## Documentation Patch Plan

Create/update:

- `products/entropy-core/docs/audit/REVIEW_REPORT.md` — current Phase 0 consolidated review.
- `products/entropy-core/docs/audit/NEXT_PHASE_PLAN.md` — next-stage plan from this strategy review.
- `products/entropy-core/docs/tasks.md` — add Phase 0 closure/hardening or Phase 1 planning tasks
  after human decision.
- `products/entropy-core/docs/CODEX_PROMPT.md` — set next task to the human decision or first approved
  hardening task.
- `products/entropy-core/docs/EVIDENCE_INDEX.md` — add strategy review and future hardening evidence.
- Optional ADRs for formula/evidence decisions once the human chooses priorities.

## Go / No-Go Recommendation

CONDITIONAL_GO for planning and documentation hardening.

NO_GO for Phase 1 implementation, live data, live capital, OOS claims, or
phase-gate approval until PSR-001 and PSR-002 are resolved.
